Prostate Cancer Connect
  • Saved

Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis - PubMed

Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34598843/

Nodal SBRT yielded encouraging DFS and ADT-free survival in this population. Only a minority of patients developed prostate bed recurrence, suggesting that local treatment may be safely avoided. A consistent...

  • Saved

How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer? - PubMed

How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer? - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34599724/

Discontinuation of PSA monitoring could be discussed with patients with intermediate-risk PCa as a reasonable option if PSA levels remain ≤0.1 ng/mL at 5 years after LDR-BT, either alone or...

  • Saved

Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer - PubMed

Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34597380/

doi: 10.1093/jnci/djab196. Online ahead of print. 1 Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY, USA. 2 Memorial Sloan Kettering Cancer Center, Department of Medicine,...

  • Saved

Initial dose reduction of enzalutamide does not decrease the incidence of adverse events in castration-resistant prostate cancer - PubMed

Initial dose reduction of enzalutamide does not decrease the incidence of adverse events in castration-resistant prostate cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34597353/

Initiating treatment with a reduced dose of enzalutamide did not significantly decrease the incidence rate of AEs, and it showed poorer PSA response rate. There is no clear rationale for...

  • Saved

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC) - PubMed

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC) - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34557366/

Non-alcoholic fatty liver disease (NAFLD) is a fast-spreading epidemic across the globe and has serious implications far beyond that of a "benign" liver condition. It is usually an outcome of...

  • 4yr
    Key Points • Conclusion/Relevance: “Chronic positive energy balance overwhelms safe fat storage depots in subcutaneous WAT [white adipose tissue], leading to ectopic fat storage in unsafe sites such as VAT [visceral Show More